Creative Biolabs-Immuno-oncology

Anti-CD22 (clone RFB3-4F) SynExpress SV-mCh-cJ-H CD8+ T Cells (CAT#: ITS-1124-CR492)

DatasheetDatasheet
Description
This product utilizes CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target CD22 ( clone RFB3-4F). We employs the pGEM (SV40-mCherry-c-Jun-HindIII) vector components and the SynExpress system of the exons Knock-in/Negative feedback for a robust and sustained response against cancers.
Host
Humanized
Target
CD22
Clone
RFB3-4F
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
mCherry
Promoter
SV40
Effector Gene
c-Jun
Insertion Sites
HindIII
Gene Modification
Knock-in
Modification Domain
Exons
Carrier Type
pGEM
Transformation Accuracy
0.99
Cell Culture
Microcarrier Culture
Related Products

For Research Use Only | Not For Clinical Use

Online Inquiry
Copyright © 2026 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.